ELCC 2015 News: ‘Real-World’ EGFR Mutation Frequency Results From a Large Population of Chemotherapy Naive Patients With Advanced NSCLC By Ogkologos - April 16, 2015 402 0 Facebook Twitter Google+ Pinterest WhatsApp Final results from the IGNITE study Source RELATED ARTICLESMORE FROM AUTHOR A Short-Course Dose Escalation Strategy Could Improve Ability to Reach Target Dose of Adjuvant Abemaciclib in High-Risk Early-Stage HR-positive, HER2-negative Breast Cancer FDA Approves Ziftomenib for Relapsed or Refractory Acute Myeloid Leukaemia with a NPM1 Mutation NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared with SoC Antiemetic Prophylaxis MOST POPULAR Mapping Cancer Genomic Evolution Offers Insights into Tumor Development March 6, 2020 Experts Propose a Clinical Definition of Acquired Resistance to PD-(L)1 Blockade... September 7, 2021 After Lung Cancer Screening, Follow-Up Procedures May Be Riskier than Thought February 8, 2019 Study Details Long-Term Side Effects of Immune Checkpoint Inhibitors April 30, 2021 Load more HOT NEWS 2-Year-Boy Is So Excited To See Himself In Disney’s ‘Encanto’ Whipple Procedure for Pancreatic Cancer: How to Prepare and What to... Happy New Year From Our Team Lymph Node Biopsies Are Unnecessary For Early-Stage Breast Cancer Patients, Study...
